Coronavirus Disease 2019 (COVID-19)-Associated Thromboembolic Disease: A Report of Three Patients With Pulmonary Embolism

Curēus
Jeffrey GuccioneErika Odisio

Abstract

Coagulopathy and thromboembolic disease, including pulmonary embolism (PE), are reported complications of coronavirus disease 2019 (COVID-19). The mechanism is not fully understood. We present three patients with COVID-19 and concurrent PE.

References

Jul 8, 2017·Thrombosis Research·Jeffrey A Kline
Mar 17, 2020·AJR. American Journal of Roentgenology·Sana SalehiAli Gholamrezanezhad
Apr 5, 2020·Journal of Thrombosis and Thrombolysis·Shiyu YinNing Tang
Apr 20, 2020·Journal of Thrombosis and Haemostasis : JTH·Litao ZhangZhenlu Zhang
Apr 28, 2020·Blood·Jean M Connors, Jerrold H Levy
May 15, 2020·The Lancet. Haematology·Marcel LeviJerrold H Levy
Mar 30, 2021·Radiology. Cardiothoracic Imaging·Yuanliang XieShutong Zhang

❮ Previous
Next ❯

Citations

Jul 14, 2020·Journal of Cancer Research and Clinical Oncology·Giorgia GarganeseUNKNOWN Gemelli Vul.Can MDT

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.